Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Income Statement
Earnings Waterfall
Deciphera Pharmaceuticals Inc
Revenue
|
163.4m
USD
|
Cost of Revenue
|
-3.7m
USD
|
Gross Profit
|
159.6m
USD
|
Operating Expenses
|
-370.6m
USD
|
Operating Income
|
-211m
USD
|
Other Expenses
|
16m
USD
|
Net Income
|
-194.9m
USD
|
Income Statement
Deciphera Pharmaceuticals Inc
Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
25
N/A
|
25
N/A
|
25
N/A
|
25
+0%
|
7
-71%
|
23
+216%
|
42
+86%
|
67
+60%
|
84
+25%
|
91
+9%
|
96
+5%
|
100
+4%
|
109
+9%
|
122
+12%
|
134
+10%
|
138
+3%
|
144
+4%
|
151
+5%
|
163
+8%
|
|
Gross Profit | ||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(6)
|
(9)
|
(9)
|
(7)
|
(5)
|
(4)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
7
N/A
|
22
+217%
|
42
+87%
|
67
+59%
|
82
+23%
|
89
+8%
|
93
+5%
|
97
+4%
|
106
+9%
|
116
+10%
|
125
+8%
|
129
+3%
|
137
+6%
|
146
+7%
|
160
+9%
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(26)
|
(28)
|
(33)
|
(39)
|
(51)
|
(65)
|
(77)
|
(91)
|
(104)
|
(131)
|
(157)
|
(189)
|
(226)
|
(252)
|
(280)
|
(301)
|
(313)
|
(324)
|
(341)
|
(364)
|
(393)
|
(383)
|
(364)
|
(340)
|
(308)
|
(318)
|
(335)
|
(353)
|
(371)
|
|
Selling, General & Administrative |
(6)
|
(7)
|
(8)
|
(9)
|
(11)
|
(14)
|
(17)
|
(19)
|
(21)
|
(29)
|
(38)
|
(51)
|
(68)
|
(79)
|
(96)
|
(108)
|
(114)
|
(121)
|
(124)
|
(129)
|
(136)
|
(134)
|
(131)
|
(125)
|
(120)
|
(123)
|
(126)
|
(130)
|
(136)
|
|
Research & Development |
(20)
|
(22)
|
(25)
|
(30)
|
(40)
|
(51)
|
(60)
|
(71)
|
(83)
|
(102)
|
(119)
|
(138)
|
(158)
|
(173)
|
(184)
|
(193)
|
(199)
|
(203)
|
(217)
|
(234)
|
(257)
|
(249)
|
(234)
|
(215)
|
(188)
|
(195)
|
(209)
|
(224)
|
(234)
|
|
Operating Income |
(26)
N/A
|
(28)
-9%
|
(33)
-17%
|
(39)
-19%
|
(51)
-30%
|
(65)
-28%
|
(77)
-18%
|
(91)
-18%
|
(104)
-15%
|
(131)
-26%
|
(132)
0%
|
(164)
-25%
|
(201)
-22%
|
(227)
-13%
|
(273)
-20%
|
(279)
-2%
|
(271)
+3%
|
(257)
+5%
|
(259)
-1%
|
(275)
-6%
|
(300)
-9%
|
(285)
+5%
|
(259)
+9%
|
(224)
+13%
|
(183)
+18%
|
(189)
-3%
|
(198)
-5%
|
(207)
-4%
|
(211)
-2%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
9
|
8
|
5
|
2
|
1
|
0
|
0
|
(0)
|
1
|
3
|
5
|
8
|
12
|
14
|
16
|
|
Pre-Tax Income |
(26)
N/A
|
(28)
-9%
|
(33)
-17%
|
(39)
-18%
|
(50)
-29%
|
(64)
-27%
|
(75)
-17%
|
(87)
-17%
|
(100)
-14%
|
(126)
-26%
|
(126)
+0%
|
(157)
-25%
|
(192)
-22%
|
(218)
-13%
|
(263)
-21%
|
(271)
-3%
|
(266)
+2%
|
(255)
+4%
|
(258)
-1%
|
(274)
-6%
|
(300)
-9%
|
(286)
+5%
|
(258)
+10%
|
(221)
+14%
|
(178)
+20%
|
(181)
-2%
|
(186)
-3%
|
(193)
-4%
|
(195)
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(26)
|
(28)
|
(33)
|
(39)
|
(50)
|
(64)
|
(75)
|
(87)
|
(100)
|
(126)
|
(126)
|
(157)
|
(192)
|
(218)
|
(263)
|
(271)
|
(266)
|
(255)
|
(258)
|
(274)
|
(300)
|
(286)
|
(258)
|
(221)
|
(179)
|
(182)
|
(187)
|
(194)
|
(195)
|
|
Net Income (Common) |
(26)
N/A
|
(28)
-9%
|
(33)
-17%
|
(39)
-18%
|
(50)
-29%
|
(64)
-27%
|
(75)
-17%
|
(87)
-17%
|
(100)
-14%
|
(126)
-26%
|
(126)
+0%
|
(157)
-25%
|
(192)
-22%
|
(218)
-13%
|
(263)
-21%
|
(271)
-3%
|
(266)
+2%
|
(255)
+4%
|
(258)
-1%
|
(274)
-6%
|
(300)
-9%
|
(286)
+5%
|
(258)
+10%
|
(221)
+14%
|
(179)
+19%
|
(182)
-2%
|
(187)
-3%
|
(194)
-3%
|
(195)
-1%
|
|
EPS (Diluted) |
-0.85
N/A
|
-0.92
-8%
|
-1.08
-17%
|
-1.27
-18%
|
-1.64
-29%
|
-1.96
-20%
|
-2.23
-14%
|
-2.32
-4%
|
-2.82
-22%
|
-3.3
-17%
|
-3.28
+1%
|
-3.59
-9%
|
-4.48
-25%
|
-4.06
+9%
|
-4.71
-16%
|
-4.8
-2%
|
-4.78
+0%
|
-4.41
+8%
|
-4.45
-1%
|
-4.74
-7%
|
-5.16
-9%
|
-4.89
+5%
|
-3.57
+27%
|
-2.83
+21%
|
-2.37
+16%
|
-2.19
+8%
|
-2.2
0%
|
-2.25
-2%
|
-2.29
-2%
|